$KZR Kezar Life Sciences, Inc. Insider Trading Week 25/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kezar Life Sciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kezar Life Sciences, Inc. in week 25/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2018 | KZR | Kezar Life Science ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | C | 0.00 | 472,229 | 0 | 0 | |
| Jun 28 2018 | KZR | Kezar Life Science ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 15.00 | 150,000 | 2,250,000 | 622,229 | 472.2 K to 622.2 K (+31.76 %) |
| Jun 28 2018 | KZR | Kezar Life Science ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | C | 0.00 | 472,229 | 0 | 472,229 | 0 to 472.2 K |
| Jun 27 2018 | KZR | Kezar Life Science ... | Cormorant Asset Management, LP | 10% Owner | Option Exercise | C | 0.00 | 1,007,421 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Cormorant Asset Management, LP | 10% Owner | Option Exercise | C | 0.00 | 315,488 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Cormorant Asset Management, LP | 10% Owner | Buy | P | 15.00 | 250,000 | 3,750,000 | 1,572,909 | 1.3 M to 1.6 M (+18.90 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Cormorant Asset Management, LP | 10% Owner | Buy | C | 0.00 | 1,007,421 | 0 | 1,322,909 | 315.5 K to 1.3 M (+319.32 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Cormorant Asset Management, LP | 10% Owner | Buy | C | 0.00 | 315,488 | 0 | 315,488 | 0 to 315.5 K |
| Jun 27 2018 | KZR | Kezar Life Science ... | Sommadossi Jean-Pierre | Director | Option Exercise | C | 0.00 | 35,258 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Sommadossi Jean-Pierre | Director | Option Exercise | C | 0.00 | 52,581 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Sommadossi Jean-Pierre | Director | Buy | C | 0.00 | 35,258 | 0 | 178,440 | 143.2 K to 178.4 K (+24.62 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Sommadossi Jean-Pierre | Director | Buy | C | 0.00 | 52,581 | 0 | 143,182 | 90.6 K to 143.2 K (+58.04 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Option Exercise | C | 0.00 | 1,007,422 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Option Exercise | C | 0.00 | 1,051,630 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Buy | P | 15.00 | 250,000 | 3,750,000 | 2,309,052 | 2.1 M to 2.3 M (+12.14 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Buy | C | 0.00 | 1,007,422 | 0 | 2,059,052 | 1.1 M to 2.1 M (+95.80 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Buy | C | 0.00 | 1,051,630 | 0 | 1,051,630 | 0 to 1.1 M |
| Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Option Exercise | C | 0.00 | 1,007,422 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Option Exercise | C | 0.00 | 1,051,630 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Buy | P | 15.00 | 250,000 | 3,750,000 | 2,309,052 | 2.1 M to 2.3 M (+12.14 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Buy | C | 0.00 | 1,007,422 | 0 | 2,059,052 | 1.1 M to 2.1 M (+95.80 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Buy | C | 0.00 | 1,051,630 | 0 | 1,051,630 | 0 to 1.1 M |
| Jun 27 2018 | KZR | Kezar Life Science ... | Kirk Christopher J. | President and CSO | Option Exercise | A | 5.91 | 26,690 | 157,738 | 26,690 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Kauffman Michael | Director | Option Exercise | C | 0.00 | 10,516 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Kauffman Michael | Director | Buy | C | 0.00 | 10,516 | 0 | 63,690 | 53.2 K to 63.7 K (+19.78 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Fowler John Franklin | CEO | Option Exercise | A | 5.91 | 88,967 | 525,795 | 88,967 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Option Exercise | C | 0.00 | 197,076 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Kirk Christopher J. | President and CSO | Option Exercise | A | 5.91 | 26,690 | 157,738 | 26,690 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Option Exercise | C | 0.00 | 262,907 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Buy | P | 15.00 | 50,000 | 750,000 | 563,157 | 513.2 K to 563.2 K (+9.74 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Buy | C | 0.00 | 197,076 | 0 | 513,157 | 316.1 K to 513.2 K (+62.35 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Buy | C | 0.00 | 262,907 | 0 | 316,081 | 53.2 K to 316.1 K (+494.43 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Kauffman Michael | Director | Option Exercise | C | 0.00 | 10,516 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Kauffman Michael | Director | Buy | C | 0.00 | 10,516 | 0 | 63,690 | 53.2 K to 63.7 K (+19.78 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Fowler John Franklin | CEO | Option Exercise | A | 5.91 | 88,967 | 525,795 | 88,967 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Option Exercise | C | 0.00 | 197,076 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Option Exercise | C | 0.00 | 262,907 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Aberdare Management Company, L ... | 10% Owner | Option Exercise | C | 0.00 | 31,481 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Buy | P | 15.00 | 50,000 | 750,000 | 563,157 | 513.2 K to 563.2 K (+9.74 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Aberdare Management Company, L ... | 10% Owner | Option Exercise | C | 0.00 | 105,162 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Buy | C | 0.00 | 197,076 | 0 | 513,157 | 316.1 K to 513.2 K (+62.35 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Aberdare Management Company, L ... | 10% Owner | Buy | C | 0.00 | 31,481 | 0 | 136,643 | 105.2 K to 136.6 K (+29.94 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Buy | C | 0.00 | 262,907 | 0 | 316,081 | 53.2 K to 316.1 K (+494.43 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Aberdare Management Company, L ... | 10% Owner | Buy | C | 0.00 | 105,162 | 0 | 105,162 | 0 to 105.2 K |
| Jun 27 2018 | KZR | Kezar Life Science ... | Aberdare Management Company, L ... | 10% Owner | Option Exercise | C | 0.00 | 31,481 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Aberdare Management Company, L ... | 10% Owner | Option Exercise | C | 0.00 | 105,162 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Aberdare Management Company, L ... | 10% Owner | Buy | C | 0.00 | 31,481 | 0 | 136,643 | 105.2 K to 136.6 K (+29.94 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Aberdare Management Company, L ... | 10% Owner | Buy | C | 0.00 | 105,162 | 0 | 105,162 | 0 to 105.2 K |
| Jun 26 2018 | KZR | Kezar Life Science ... | Chiesi Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 314,819 | 0 | 0 | |
| Jun 26 2018 | KZR | Kezar Life Science ... | Chiesi Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 314,819 | 0 | 314,819 | 0 to 314.8 K |
| Jun 26 2018 | KZR | Kezar Life Science ... | PAPPAS ARTHUR M | 10% Owner | Option Exercise | C | 0.00 | 23,894 | 0 | 0 | |
| Jun 26 2018 | KZR | Kezar Life Science ... | PAPPAS ARTHUR M | 10% Owner | Option Exercise | C | 0.00 | 290,924 | 0 | 0 | |
| Jun 26 2018 | KZR | Kezar Life Science ... | PAPPAS ARTHUR M | 10% Owner | Buy | C | 0.00 | 23,894 | 0 | 23,894 | 0 to 23.9 K |
| Jun 26 2018 | KZR | Kezar Life Science ... | PAPPAS ARTHUR M | 10% Owner | Buy | C | 0.00 | 290,924 | 0 | 290,924 | 0 to 290.9 K |
| Jun 25 2018 | KZR | Kezar Life Science ... | Omega Fund IV, L.P. | Option Exercise | C | 0.00 | 377,783 | 0 | 0 | ||
| Jun 25 2018 | KZR | Kezar Life Science ... | Omega Fund IV, L.P. | Option Exercise | C | 0.00 | 377,783 | 0 | 0 | ||
| Jun 25 2018 | KZR | Kezar Life Science ... | Omega Fund IV, L.P. | Option Exercise | C | 0.00 | 315,489 | 0 | 0 | ||
| Jun 25 2018 | KZR | Kezar Life Science ... | Omega Fund IV, L.P. | Option Exercise | C | 0.00 | 315,489 | 0 | 0 | ||
| Jun 25 2018 | KZR | Kezar Life Science ... | Omega Fund IV, L.P. | Buy | C | 0.00 | 377,783 | 0 | 693,272 | 315.5 K to 693.3 K (+119.75 %) | |
| Jun 25 2018 | KZR | Kezar Life Science ... | Omega Fund IV, L.P. | Buy | C | 0.00 | 377,783 | 0 | 693,272 | 315.5 K to 693.3 K (+119.75 %) | |
| Jun 25 2018 | KZR | Kezar Life Science ... | Omega Fund IV, L.P. | Buy | C | 0.00 | 315,489 | 0 | 315,489 | 0 to 315.5 K | |
| Jun 25 2018 | KZR | Kezar Life Science ... | Omega Fund IV, L.P. | Buy | C | 0.00 | 315,489 | 0 | 315,489 | 0 to 315.5 K | |
| Jun 25 2018 | KZR | Kezar Life Science ... | Onyx Therapeutics, Inc. | 10% Owner | Option Exercise | C | 0.00 | 1,121,384 | 0 | 0 | |
| Jun 25 2018 | KZR | Kezar Life Science ... | Onyx Therapeutics, Inc. | 10% Owner | Buy | C | 0.00 | 1,121,384 | 0 | 1,121,384 | 0 to 1.1 M |